PAVIKINE owner Contact Information online
from MERCK SHARP & DOHME CORP.
PAVIKINE
US serial number:85195158
Application filling date:Dec. 10, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jan. 13, 2014
Publication date:Apr. 12, 2011
Abandoned date:Jan. 13, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for the treatment of immunological disorders and disorders of the central nervous system; anti-infectives; antivirals
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Services:Pharmaceutical preparations for the treatment of immunological disorders and disorders of the central nervous system; anti-infectives; antivirals
Current owner owner name:MERCK SHARP & DOHME CORP.
Current owner owner address:ONE MERCK DRIVE
WHITEHOUSE STATION,
NEW JERSEY
UNITED STATES
08889
Current owner legal entity type:CORPORATION
Current owner state or country:NEW JERSEY
Attorney name:Christopher Bolinger
Attorney email:TrademarkUS@merck.com
Attorney email authorized:Yes
Correspondent name address:Christopher Bolinger
Merck
126 E. Lincoln Avenue
Rahway,
NEW JERSEY
UNITED STATES
07065
Correspondent phone:732-594-0922
Correspondent email:TrademarkUS@merck.com
Correspondent fax:732-594-5760
Correspondent email authorized:Yes
Trademark staff tm attorney:CLARK, ROBERT C
Trademark staff law office assigned PAVIKINE:LAW OFFICE 101
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (126) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) SANOFI (46) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) Wyeth LLC (41) Pfizer Inc. (39) Bristol-Myers Squibb Company (37) Forest Laboratories, Inc. (34) MERCK SHARP & DOHME CORP. (32) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Ares Trading S.A. (17) Scott Riddell (17)Popular publication dates
Apr. 12, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Mar. 29, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
